Bio-Techne (TECH) Non-Current Deferred Tax Liability (2011 - 2026)

Bio-Techne's Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $14.2 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability fell 55.49% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $14.2 million (down 55.49% YoY), while the FY2025 annual figure was $6.2 million, down 88.96% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $14.2 million, up from $11.0 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $112.9 million in Q3 2022, with the low at $4.1 million in Q3 2023.
• The 5-year median for Non-Current Deferred Tax Liability is $55.9 million (2024), against an average of $56.7 million.
• The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability tumbled 96.37% in 2023, then jumped 1119.93% in 2024.
• Bio-Techne's Non-Current Deferred Tax Liability stood at $111.4 million in 2022, then tumbled by 35.74% to $71.6 million in 2023, then sank by 47.3% to $37.7 million in 2024, then sank by 70.78% to $11.0 million in 2025, then increased by 28.94% to $14.2 million in 2026.
• Business Quant data shows TECH's Non-Current Deferred Tax Liability at $14.2 million in Q1 2026, $11.0 million in Q4 2025, and $11.3 million in Q3 2025.